Compare JAMF & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAMF | LMAT |
|---|---|---|
| Founded | 2002 | 1983 |
| Country | United States | United States |
| Employees | 2595 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2020 | 2006 |
| Metric | JAMF | LMAT |
|---|---|---|
| Price | $13.03 | $83.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $15.56 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 1.3M | 177.9K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | N/A | ★ 27.40 |
| EPS | N/A | ★ 2.32 |
| Revenue | ★ $690,590,000.00 | $240,866,000.00 |
| Revenue This Year | $15.30 | $15.17 |
| Revenue Next Year | $9.17 | $9.07 |
| P/E Ratio | ★ N/A | $36.00 |
| Revenue Growth | 12.28 | ★ 13.07 |
| 52 Week Low | $7.09 | $71.42 |
| 52 Week High | $16.12 | $105.55 |
| Indicator | JAMF | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 75.87 | 48.93 |
| Support Level | $12.96 | $79.40 |
| Resistance Level | $13.02 | $86.00 |
| Average True Range (ATR) | 0.02 | 2.23 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 77.78 | 46.71 |
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.